Analysis of interaction of Sendai virus V protein and melanoma differentiation-associated gene 5

Microbiology and Immunology

Volumn 55, Issue 11, 2011, Pages 760-767

  Sakaguchi, Takemasa ^a   Irie, Takashi ^a,b   Kuwayama, Masaru ^a,c   Ueno, Tatsuya ^a   Yoshida, Asuka ^a   Kawabata, Ryoko ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA PREFECTURAL TECHNOLOGY RESEARCH INSTITUTE   (Japan)

^c Kamo Psychiatry Medical Center   (Japan)

Author keywords

MDA5; Sendai virus V protein

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; MELANOMA DIFFERENTIATION ASSOCIATED GENE 5 PROTEIN; RETINOIC ACID INDUCIBLE PROTEIN I; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS PROTEIN V;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MELANOMA DIFFERENTIATION ASSOCIATED GENE 5; NUCLEOTIDE SEQUENCE; PATHOGENICITY; POINT MUTATION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SENDAI VIRUS; VIRUS GENE; VIRUS VIRULENCE;

ANIMALS; CELL LINE; DEAD-BOX RNA HELICASES; HUMANS; IMMUNOPRECIPITATION; INTERFERON REGULATORY FACTOR-3; MICE; MUTANT PROTEINS; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; TRANS-ACTIVATORS; VIRAL PROTEINS;

RODENTIA; SENDAI VIRUS;

EID: 81155133315     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2011.00379.x     Document Type: Article

References (38)

1. Lamb R.A., Parks G.D. (2006) Paramyxoviridae: the viruses and their replication. In Knipe D.M., Howley P.M. eds. Fields Virology, 5th edn. Philadelphia Lippincott Williams & Wilkins, pp 1449-1496.
2. Thomas S.M., Lamb R.A., Paterson R.G. (1988) Two mRNAs that differ by two nontemplated nucleotides encode the amino coterminal proteins P and V of the paramyxovirus SV5. Cell 54: 891-902.
3. Vidal S., Curran J., Kolakofsky D. (1990) Editing of the Sendai virus P/C mRNA by G insertion occurs during mRNA synthesis via a virus-encoded activity. J Virol 64: 239-46.
4. Liston P., Briedis D.J. (1994) Measles virus V protein binds zinc. Virology 198: 399-404.
5. Paterson R.G., Leser G.P., Shaughnessy M.A., Lamb R.A. (1995) The paramyxovirus SV5 V protein binds two atoms of zinc and is a structural component of virions. Virology 235: 360-6.
6. Li T., Chen X., Garbutt K.C., Zhou P., Zheng N. (2006) Structure of DDB1 in complex with a paramyxovirus V protein: viral hijack of a propeller cluster in ubiquitin ligase. Cell 124: 105-17.
7. Nagai Y. (1999) Paramyxovirus replication and pathogenesis. Reverse genetics transforms understanding. Rev Med Virol 9: 83-99.
8. Sakaguchi T., Kato A., Kiyotani K., Yoshida T., Nagai Y. (2008) Studies on the paramyxovirus accessory genes by reverse genetics in the Sendai virus-mouse system. Proc Jpn Acad Ser B Phys Biol Sci 84: 439-51.
9. Kato A., Kiyotani K., Sakai Y., Yoshida T., Nagai Y. (1997) The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO J 16: 578-87.
10. Kato A., Kiyotani K., Sakai Y., Yoshida T., Shioda T., Nagai Y. (1997) Importance of the cysteine-rich carboxyl-terminal half of V protein for Sendai virus pathogenesis. J Virol l71: 7266-72.
11. Huang C., Kiyotani K., Fujii Y., Fukuhara N., Kato A., Nagai Y., Yoshida T., Sakaguchi T. (2000) Involvement of the zinc-binding capacity of Sendai virus V protein in viral pathogenesis. J Virol 74: 7834-41.
12. Fukuhara N., Huang C., Kiyotani K., Yoshida T., Sakaguchi T. (2002) Mutational analysis of the Sendai virus V protein: importance of the conserved residues for Zn binding, virus pathogenesis, and efficient RNA editing. Virology 299: 172-81.
13. Kiyotani K., Sakaguchi T., Kato A., Nagai Y., Yoshida T. (2007) Paramyxovirus Sendai virus V protein counteracts innate virus clearance through IRF3 activation, but not via interferon, in mice. Virology 359: 82-91.
14. Kawai T., Akira S. (2006) Innate immune recognition of viral infection. Nat Immunol 7: 131-7.
15. Akira S., Uematsu S., Takeuchi O. (2006) Pathogen recognition and innate immunity. Cell 124: 783-801.
16. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., Taira K., Akira S., Fujita T. (2004) The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5: 730-7.
17. Hornung V., Ellegast J., Kim S., Brzozka K., Jung A., Kato H., Poeck H., Akira S., Conzelmann K.K., Schlee M., Enders S., Hartmann G. (2006) 5'-Triphosphate RNA is the ligand for RIG-I. Science 314: 994-7.
18. Pichlmair A., Schulz O., Tan C.P., Naslund T.I., Liljestrom P., Weber F., Reis e Sousa C. (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science 314: 997-1001.
19. Andrejeva J., Childs K.S., Young D.F., Carlos T.S., Stock N., Goodbourn S., Randall R.E. (2004) The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci USA 101: 17264-9.
20. Yoneyama M., Kikuchi M., Matsumoto K., Imaizumi T., Miyagishi M., Taira K., Foy E., Loo YM., Gale M. Jr., Akira S., Yonehara S., Kato A., Fujita T. (2005) Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 175: 2851-8.
21. Kato A., Sakai Y., Shioda T., Kondo T., Nakanishi M., Nagai Y. (1996) Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells 1: 569-79.
22. Kawai T., Takahashi K., Sato S., Coban C., Kumar H., Kato H., Ishii K.J., Takeuchi O., Akira S. (2005) IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 6: 981-8.
23. Niwa H., Yamamura K., Miyazaki J. (1991) Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108: 193-9.
24. Sugahara F., Uchiyama T., Watanabe H., Shimazu Y., Kuwayama M., Fujii Y., Kiyotani K., Adachi A., Kohno N., Yoshida T., Sakaguchi T. (2004) Paramyxovirus Sendai virus-like particle formation by expression of multiple viral proteins and acceleration of its release by C protein. Virology 325: 1-10.
25. Kato A., Cortese-Grogan C., Moyer S.A., Sugahara F., Sakaguchi T., Kubota T., Otsuki N., Kohase M., Tashiro M., Nagai Y. (2004) Characterization of the amino acid residues of Sendai virus C protein that are critically involved in its interferon antagonism and RNA synthesis down-regulation. J Virol 78: 7443-54.
26. Sakaguchi T., Leser G.P., Lamb R.A. (1996) The ion channel activity of the influenza virus M2 protein affects transport through the Golgi apparatus. J Cell Biol 133: 733-47.
27. Irie T., Nagata N., Igarashi T., Okamoto I., Sakaguchi T. (2010) Conserved charged amino acids within Sendai virus C protein play multiple roles in the evasion of innate immune responses. PLoS One 5: e10719.
28. Komatsu T., Takeuchi K., Gotoh B. (2007) Bovine parainfluenza virus type 3 accessory proteins that suppress beta interferon production. Microbes Infect 9: 954-62.
29. Hale B.G., Randall R.E., Ortin J., Jackson D. (2008) The multifunctional NS1 protein of influenza A viruses. J Gen Virol 89: 2359-76.
30. Childs K., Andrejeva J., Randall R., Goodbourn S. (2009) Mechanism of mda-5 Inhibition by paramyxovirus V proteins. J Virol 83: 1465-73.
31. Childs K., Stock N., Ross C., Andrejeva J., Hilton L., Skinner M., Randall R., Goodbourn S. (2007) mda-5, but not RIG-I, is a common target for paramyxovirus V proteins. Virology 359: 190-200.
32. Kato H., Sato S., Yoneyama M., Yamamoto M., Uematsu S., Matsui K., Tsujimura T., Takeda K., Fujita T., Takeuchi O., Akira S. (2005) Cell type-specific involvement of RIG-I in antiviral response. Immunity 23: 19-28.
33. Melchjorsen J., Jensen S.B., Malmgaard L., Rasmussen S.B., Weber F., Bowie A.G., Matikainen S., Paludan S.R. (2005) Activation of innate defense against a paramyxovirus is mediated by RIG-I and TLR7 and TLR8 in a cell-type-specific manner. J Virol 79: 12944-51.
34. Loo Y.M., Fornek J., Crochet N., Bajwa G., Perwitasari O., Martinez-Sobrido L., Akira S., Gill M.A., Garcia-Sastre A., Katze M.G., Gale M. Jr. (2008) Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 82: 335-45.
35. Kato H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., Matsui K., Uematsu S., Jung A., Kawai T., Ishii K.J., Yamaguchi O., Otsu K., Tsujimura T., Koh C.S., Reis e Sousa C., Matsuura Y., Fujita T., Akira S. (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441: 101-5.
36. Gitlin L., Benoit L., Song C., Cella M., Gilfillan S., Holtzman M.J., Colonna M. (2010) Melanoma differentiation-associated gene 5 (MDA5) is involved in the innate immune response to Paramyxoviridae infection in vivo. PLoS Pathog 6: e1000734.
37. Diao F., Li S., Tian Y., Zhang M., Xu L.G., Zhang Y., Wang R.P., Chen D., Zhai Z., Zhong B., Tien P., Shu H.B. (2007) Negative regulation of MDA5- but not RIG-I-mediated innate antiviral signaling by the dihydroxyacetone kinase. Proc Natl Acad Sci USA 104: 11706-11.
38. Ikegame S., Takeda M., Ohno S., Nakatsu Y., Nakanishi Y., Yanagi Y. (2010) Both RIG-I and MDA5 RNA helicases contribute to the induction of alpha/beta interferon in measles virus-infected human cells. J Virol 84: 372-9.